CEO and President
Thu, Jun 15, 2023
Jun 15
8,012 shares @ $21.90
Decreased holdings by -16.70%
10th largest trade (out of 107)
Cluster Buy
Trade made by an officer
Part of a cluster of 2 transactions by 2 insiders
10b5-1 scheduled trade
46% win rate · +5.4% median edge vs SPY (11 trades, 90-day · small sample)
Insider trade was 94% below market price
Price 7% above 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+12.20%
3M—
6M—
1Y—